Whitepapers/App Notes/Posters

Whitepaper: Why extractables and leachables matter

Posted: 18 February 2021 | | No comments yet

Medicines and other healthcare products rely for their value, integrity and commercial longevity on a delicate balance between quality, safety and efficacy.

Medicines and other healthcare products rely for their value, integrity and commercial longevity on a delicate balance between quality, safety and efficacy. When that balance is disturbed by issues such as product adulteration, the damage to patients, revenues and corporate reputation can be substantial.

That is why the pharmaceutical and medtech industries, along with their associated regulators, are paying increasing attention to testing requirements for extractables and leachables (E&L). Recent trends in product development and manufacturing have multiplied the risks of unintended chemical changes that could compromise product integrity either during the manufacturing process or on the shelf.












    To read this whitepaper in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Nelson Labs

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Send this to a friend